Join the 'Skin and Structure Infection' group to help and get support from people like you. How it works
Skin and Structure Infection Blog
Related terms: Complicated Skin and Skin Structure Infection, cSSSI
| Tweet |
FDA Approves Teflaro for Bacterial Infections
Posted 1 Nov 2010 by Drugs.com
SILVER SPRING, Md., Oct. 29 /PRNewswire-USNewswire/ – The U.S. Food and Drug Administration today approved Teflaro (ceftaroline fosamil), an injectable antibiotic to treat adults with community acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI), including methicillin-resistant Staphylococcus aureus (MRSA). Teflaro is an antibacterial agent in a class of drugs known as cephalosporins, which act by interfering with the bacterial cell wall. CABP is a bacterial infection that develops in the lungs of patients who are exposed to the bacteria in their normal environment, and not in the hospital. ABSSSI is a bacterial infection of skin and skin structures that requires antibiotic treatment and may require surgical treatment. MRSA is a type of staph bacteria that is resistant to certain antibiotics. These antibiotics include methicillin and ... Read more
Related support groups: Pneumonia, Skin and Structure Infection
Theravance and Astellas Announce FDA Approval of Vibativ (telavancin) for the Treatment of Complicated Skin and Skin Structure Infections
Posted 2 Dec 2009 by Drugs.com
SOUTH SAN FRANCISCO, CA and DEERFIELD, IL - September 11, 2009 - Theravance, Inc. and Astellas Pharma US, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Vibativ (telavancin) for the treatment of adult patients with complicated skin and skin structure infections (cSSSI) caused by susceptible Gram-positive bacteria, including Staphylococcus aureus, both methicillin-resistant (MRSA) and methicillin-susceptible (MSSA) strains. Vibativ is a bactericidal, once-daily injectable lipoglycopeptide antibiotic discovered by Theravance. "We are very pleased with the FDA's approval of Vibativ, and extremely excited about the prospect of bringing this new medicine to the market," said Rick E Winningham, Theravance's Chief Executive Officer. "This is a significant event that marks the first approved indication for Vibativ and validates Theravance's strategies in drug ... Read more
Related support groups: Skin and Structure Infection
Ask a Question
Further Information
Related Condition Support Groups
Deep Neck Infection, Infections
Related Drug Support Groups
Augmentin, Bactroban, Biaxin, Avelox, minocycline, mupirocin, clarithromycin, cefdinir, Omnicef, view more... cefuroxime, Rocephin, Ceftin, cloxacillin, ceftriaxone, Zyvox, cefaclor, cefadroxil, cefepime, amoxicillin/clavulanate, Cubicin, Ceclor, Duricef, daptomycin, Biaxin XL, meropenem, Augmentin XR, nafcillin, Bactroban Nasal, moxifloxacin, Minocin, cephradine, Centany, linezolid, Primaxin IM, cilastatin/imipenem, Teflaro, cefoxitin, Ceclor CD, Velosef, tea tree, Spectracef, goldenseal, Monocid, Kefurox, Nallpen, Ceclor Pulvules, Augmentin ES-600, Myciguent, Centany Kit, Avelox IV, OraMagic Rx, Tegopen, Vibativ, Trovan, Omnicef Omni-Pac, G-Myticin, Cloxapen, Garamycin Topical, Unipen, Merrem Novaplus, Spectrobid, Dynacin, Azactam, Amoclan, cefditoren, Maxipime, Mefoxin, ceftaroline, telavancin, ceftazidime, tigecycline, trovafloxacin, cefonicid, Fortaz, Tazicef, Raniclor, Primaxin IV, Ceptaz, Tazidime, Tygacil, aztreonam, Zinacef, Merrem, Myrac, bacampicillin, Tazicef Novaplus